In her role with Precede Biosciences, an early-stage liquid biopsy company, Corrie drives external research and collaborations focused on maximizing the impact of a novel plasma-based technology to improve the lives of patients. She is the former Deputy Director of Count Me In, a patient-partnered genomics initiative of the Broad Institute of MIT and Harvard. Corrie is an angiosarcoma survivor and co-founded and serves as President of Angiosarcoma Awareness, a nonprofit that supports research and awareness efforts surrounding this exceedingly rare endothelial cell cancer.
Alliance for Rare Cancers I Jedi Rare Cancer Foundation
P.O. Box 683501, Park City, Utah 84068
The Alliance for Rare Cancers is a fiscally sponsored program of the Jedi Rare Cancer Foundation, a 501(c)(3) nonprofit organization, accepting tax-deductible donations from individuals, corporations, family-advised funds, and foundations. Federal Tax ID 86-2610819. All donations are tax deductible as allowed by law.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.